Informa TechTarget Posts H1 2026 Revenue of £165M and Adjusted Operating Profit of £4.7M
TTGT sits 34% above its 52-week low of $3.37.
Summary
Informa TechTarget reported H1 2026 revenue of £165.0 million and adjusted operating profit of £4.7 million, while reaffirming full-year guidance. The update reveals narrowing losses and improving underlying trends ahead of Informa PLC's half-year results.
Key Events · Earnings and Guidance · TTGT
-
H1 2026 Revenue of £165.0M
Revenue declined 3.8% year-over-year from £171.6M, but underlying growth improved to -1.3% from -4.3% in H1 2025.
-
Adjusted Operating Profit of £4.7M
Adjusted operating profit swung to a £4.7M gain from £0.2M in H1 2025, reflecting cost discipline and merger synergies.
-
Statutory Operating Loss Narrows to £41.2M
Statutory operating loss improved significantly from £535.4M in H1 2025, driven by lower amortization and integration costs.
-
Full-Year Revenue Growth Guidance Reaffirmed
Informa reconfirmed its 2026 revenue growth outlook for Informa TechTarget, signaling confidence in the second-half trajectory.
Analysis · TTGT · Technology
Ahead of majority owner Informa PLC's results, TechTarget delivered a half-year update that signals meaningful progress in its post-merger integration. Revenue came in at £165.0 million, a 3.8% decline year-over-year, yet underlying growth improved to -1.3% from -4.3% a year ago. Adjusted operating profit swung to a £4.7 million gain from near breakeven, while the statutory operating loss narrowed dramatically to £41.2 million from £535.4 million. Full-year revenue growth guidance was reaffirmed, pointing to stabilization after the transformative merger. This first concrete look at post-merger performance suggests the integration is on track, even as top-line contraction persists.
At the time of this filing, TTGT was trading at $4.52 on NASDAQ in the Technology sector, with a market capitalization of approximately $326.8M. The 52-week trading range was $3.37 to $8.50. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.